Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00812877 · ClinicalTrials.gov registry record · NA
Pulp Capping With Two Different Agents
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 376
- Enrollment target
NCT00812877 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 376 participants.
The verdict
NCT00812877, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 376 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if MTA or calcium hydroxide are more effective as pulp capping agents
Interventions
- DRUG Mineral Trioxide Aggregate
- DRUG Calcium Hydroxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 376 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00812877
The ClinicalTrials.gov registry entry for NCT00812877 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 376 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mineral Trioxide Aggregate is the first listed.
NCT00812877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00812877 about?
NCT00812877 is a clinical study titled "Pulp Capping With Two Different Agents". The purpose of this study is to determine if MTA or calcium hydroxide are more effective as pulp capping agents
What is the current status of trial NCT00812877?
This trial is currently completed. It is a NA study. The enrollment target is 376 participants. The study started on 2009-05. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00812877?
The interventions under investigation include: Mineral Trioxide Aggregate (DRUG), Calcium Hydroxide (DRUG).
Who is sponsoring clinical trial NCT00812877?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.